These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32598995)
1. The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study. Zhang D; Song X; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; D'Ascenzo F; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Alexopoulos D; Liebetrau C; Kawaji T; Moretti C; Huczek Z; Nie S; Fujii T; Correia L; Kawashiri MA; Southern D; Kalpak O Int J Cardiol; 2020 Nov; 318():1-6. PubMed ID: 32598995 [TBL] [Abstract][Full Text] [Related]
2. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study. Iannaccone M; D Ascenzo F; De Filippo O; Gagliardi M; Southern DA; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Moretti C; Gaita F; Kalpak O; Kedev S Am J Cardiovasc Drugs; 2017 Feb; 17(1):61-71. PubMed ID: 27738920 [TBL] [Abstract][Full Text] [Related]
3. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction. Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806 [TBL] [Abstract][Full Text] [Related]
4. Evidence-Based Optimal Medical Therapy and Mortality in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention. Lee K; Han S; Lee M; Kim DW; Kwon J; Park GM; Park MW J Am Heart Assoc; 2023 May; 12(10):e024370. PubMed ID: 37158100 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin-Converting Enzyme Inhibitor-based Versus Angiotensin Receptor Blocker-based Optimal Medical Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study. Park S; Kim YG; Ann SH; Park HW; Suh J; Roh JH; Cho YR; Han S; Park GM J Cardiovasc Pharmacol; 2021 Jan; 77(1):61-68. PubMed ID: 33165139 [TBL] [Abstract][Full Text] [Related]
6. Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. Quadri G; D'Ascenzo F; Moretti C; D'Amico M; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Omedè P; Montefusco A; Giordana F; Scarano S; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Kalpak O; Kedev S; Varbella F; Gaita F EuroIntervention; 2017 Jul; 13(4):407-414. PubMed ID: 28169217 [TBL] [Abstract][Full Text] [Related]
7. Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin ii type i receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry - National Institute of Health. Ahn JH; Hyun JY; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Park HS; Kim DI; Hur SH; Oh SK; Ahn Y Cardiol J; 2021; 28(5):738-745. PubMed ID: 33001422 [TBL] [Abstract][Full Text] [Related]
9. Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction. Zhang D; Gao H; Song X; Raposeiras-Roubín S; Abu-Assi E; Paulo Simao Henriques J; D'Ascenzo F; Saucedo J; Ramón González-Juanatey J; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Alexopoulos D; Liebetrau C; Kawaji T; Moretti C; Huczek Z; Nie S; Fujii T; Correia L; Kawashiri MA; Southern D; Kalpak O; Diabetes Res Clin Pract; 2023 Sep; 203():110833. PubMed ID: 37478977 [TBL] [Abstract][Full Text] [Related]
10. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study. Resor CD; Nathan A; Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Gabriel Steg P; Hsieh WH; Mauri L; Circulation; 2016 Oct; 134(14):989-998. PubMed ID: 27576774 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711 [TBL] [Abstract][Full Text] [Related]
12. Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry. Cirillo P; Di Serafino L; Taglialatela V; Calabrò P; Antonucci E; Gresele P; Palareti G; Patti G; Pengo V; Pignatelli P; Marcucci R Angiology; 2020 Mar; 71(3):235-241. PubMed ID: 31867981 [TBL] [Abstract][Full Text] [Related]
13. Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand. Wongsalap Y; Kengkla K; Poolpun D; Saokaew S J Cardiol; 2021 Jun; 77(6):669-676. PubMed ID: 33455848 [TBL] [Abstract][Full Text] [Related]
14. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry. Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514 [TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry. Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y Am J Cardiovasc Drugs; 2019 Aug; 19(4):403-414. PubMed ID: 30788675 [TBL] [Abstract][Full Text] [Related]
16. The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension. Her AY; Choi BG; Rha SW; Kim YH; Choi CU; Jeong MH PLoS One; 2020; 15(11):e0242314. PubMed ID: 33253206 [TBL] [Abstract][Full Text] [Related]
17. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry. Kurz DJ; Radovanovic D; Seifert B; Bernheim AM; Roffi M; Pedrazzini G; Windecker S; Erne P; Eberli FR Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):13-22. PubMed ID: 25614494 [TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry. Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI; Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396 [TBL] [Abstract][Full Text] [Related]
19. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction. Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805 [TBL] [Abstract][Full Text] [Related]
20. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects. De Filippo O; D'Ascenzo F; Raposeiras-Roubin S; Abu-Assi E; Peyracchia M; Bocchino PP; Kinnaird T; Ariza-Solé A; Liebetrau C; Manzano-Fernández S; Boccuzzi G; Henriques JPS; Templin C; Wilton SB; Omedè P; Velicki L; Xanthopoulou I; Correia L; Cerrato E; Rognoni A; Fabrizio U; Nuñez-Gil I; Iannaccone M; Montabone A; Taha S; Fujii T; Durante A; Song X; Gili S; Magnani G; Varbella F; Kawaji T; Blanco PF; Garay A; Quadri G; Alexopoulos D; Caneiro Queija B; Huczek Z; Cobas Paz R; González Juanatey JR; Cespón Fernández M; Nie SP; Muñoz Pousa I; Kawashiri MA; Gallo D; Morbiducci U; Conrotto F; Montefusco A; Dominguez-Rodriguez A; López-Cuenca A; Cequier A; Iñiguez-Romo A; Usmiani T; Rinaldi M; De Ferrari GM Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):31-42. PubMed ID: 31511896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]